The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

In a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a ...

Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...

Medications are often an important part of IBD treatment. IBD is an immune-mediated disease that causes persistent inflammation in the GI tract. Without treatment, it can continue to damage the GI ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

effective treatment, and improved quality of life. One of the hallmark symptoms of IBD is abdominal discomfort, often accompanied by cramping. In Crohn’s disease, this pain is typically located ...

Major Cause of Inflammatory Bowel Disease Discovered June ... 2024 — A large-scale clinical trial of treatment strategies for Crohn's disease has shown that offering early advanced therapy ...

Women with inflammatory bowel disease who delivered a twin gestation ... The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Inflammatory Bowel Disease (IBD) is a term for chronic inflammatory conditions affecting the digestive tract, primarily Crohn ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® ...